Calendrier des promotions MicroPort CardioFlow Medtech Corporation
Calendrier avancé
Graphique simple
À propos de l'entreprise
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
Changement de prix par jour: |
0% (0.1293) |
Changement de prix par semaine: |
0% (0.1293) |
Changement de prix par mois: |
-60.82% (0.33) |
Changement de prix sur 3 mois: |
-60.82% (0.33) |
Changement de prix sur six mois: |
-60.82% (0.33) |
Changement de prix par an: |
-60.82% (0.33) |
Evolution des prix depuis le début de l'année: |
-60.82% (0.33) |
|
Sous-estimation
Nom |
Signification |
Grade |
P/S |
16.9 |
1 |
P/BV |
0.3427 |
10 |
P/E |
0 |
0 |
EV/EBITDA |
0 |
0 |
Total: |
|
3.88 |
|
Efficacité
Nom |
Signification |
Grade |
ROA, % |
-2.57 |
0 |
ROE, % |
-2.85 |
0 |
Total: |
|
0 |
|
|
Dividendes
Nom |
Signification |
Grade |
Div yield, % |
0 |
0 |
DSI |
0 |
0 |
Total: |
|
0 |
|
Devoir
Nom |
Signification |
Grade |
Debt/EBITDA |
0 |
10 |
Total: |
|
10 |
|
Impulsion de croissance
Nom |
Signification |
Grade |
Rentabilité Revenue, % |
-50.42 |
0 |
Rentabilité Ebitda, % |
0 |
0 |
Rentabilité EPS, % |
-82.22 |
0 |
Total: |
|
0 |
|
Superviseur |
Titre d'emploi |
Paiement |
Année de naissance |
Mr. Jeffrey R Lindstrom |
President, GM & Executive Director |
N/A |
1967 (57 années) |
Ms. Luying Yan |
VP & Executive Director |
N/A |
1982 (42 année) |
Mr. Liang Zhao |
Executive Director & First VP of Total Solutions |
N/A |
1980 (44 année) |
Ms. Xiangmei Li |
Joint Company Secretary |
N/A |
|
Ms. Lok Yee Chan A.C.I.S., A.C.S. |
Joint Company Secretary |
N/A |
1990 (34 année) |